MaxTwo

High-throughput, high-resolution functional imaging

CMOS-based multiwell high-density microelectrode array platform

  • iPSC-derived cells
  • Safety pharmacology and toxicology
  • Drug discovery

MaxOne

High-resolution live cell imaging platform

  • Label-free detection of sub-cellular and network activity
  • Selective electrical stimulation
  • Comprehensive data analysis tools
Learn more

Electronics + Biology

MaxOne is a CMOS-based High-Density Microelectrode Array (HD-MEA) System.

This enables compact yet powerful amplifiers, filters, and digitizers to be integrated within the MEA well—close to the cells under study.

Every Cell Counts

With MaxOne, each cell on the MEA can be accessed by multiple electrodes for recording and stimulation.

MaxOne enables long term monitoring of single cell activity, as well as the dynamics of the entire network.

MaxWell Biosystems at the Annual Meeting of the Japanese Neuroscience Society (JNS) 2017

MaxWell Biosystems travelled to Chiba, Japan and exhibited at the 40th Annual Meeting of the Japanese Neuroscience Society from July 20th to 23rd. CEO, Dr. Urs Frey, and Dr. Marie Obien were excited to show off both the MaxOne and MaxTwo systems at this year’s Japanese neuroscience conference focused on “Pushing the Boundaries of Neuroscience.” MaxWell Biosystems received a warm reception from the Japanese neuroscience community, and we look forward to connecting with researchers excited about using the MaxOne and MaxTwo. We will return to the conference next year in…

Read More

MaxWell Biosystems at ISSCR2017 Annual Meeting

MaxWell Biosystems had a great time at the ISSCR2017 Annual Meeting in Boston. The conference was held on the 14th to 17th of June at the Boston Convention and Exhibition Center. The ISSCR annual meeting brought together stem cell researchers from all over the world  aiming to create strong research networks and new opportunities to push forward the research about degenerative and rare diseases. One of the highlights of the meeting was the talk of Prof. Dr. Shinya Yamanaka, who received a Nobel Prize…

Read More

MaxWell Biosystems at venture leaders Life Science 2017 in Boston

From the 12th to the 16th of June MaxWell Biosystems and other nine Swiss Life Science startups participated in the business-boosting venture leaders Life Science program, held in Boston. It was an inspiring week, co-organized by swissnex Boston, with pitching events, company visits, and meetings with VCs and experts. Indeed, it was a great opportunity for the ten selected startups to take the first steps towards global expansion. The ten startups met medtech and biotech industry experts who gave motivating feedback on different aspects of business development. The…

Read More

MaxWell Biosystems wins Venture Kick

MaxWell Biosystems passes the final stage of Venture Kick and wins CHF 100’000. After presenting at the final stage, MaxWell Biosystems convinced the Venture Kick jury and secured CHF 100’000, in addition to CHF 30’000 already granted in previous stages. Venture Kick supports the first steps of the realization of a business idea and awards selected start-ups with up to CHF 130’000 seed money. The final stage serves as the culmination of the year-long journey of MaxWell Biosystems with Venture Kick. The journey started last July…

Read More

MaxWell Biosystems featured in ETH News

MaxWell Biosystems gets more media coverage. ETH Zurich News features the spin-off company MaxWell Biosystems. The article highlights the company’s core technology developed in Hierlemann Lab (D-BSSE) and the motivation to commercialize thanks to the demand of induced pluripotent stem cell boom. Link to English version >> Link to German version >>

Read More
Contacts






Albisriederstrasse 253
8047 Zurich, Switzerland

+41 44 244 24 24

info@mxwbio.com